Noventra Pharma Ozempic Research Compound peptide Pen-Semaglutide 6mg - 2ml
Weight Management • Appetite Control • Blood Sugar Support
Noventra Pharma Semaglutide 6mg / 2ml is a compounded peptide pen formulation designed for precision dosing and structured research applications. This pre-filled pen system is engineered for consistency, stability, and ease of use, making it suitable for controlled laboratory and metabolic research environments.
Semaglutide is widely associated with GLP-1 receptor agonist activity and is commonly researched in relation to metabolic function, glucose regulation pathways, appetite control, and energy balance mechanisms. The pen format allows for accurate, repeatable dosing within research protocols requiring consistency and reliability.
Key Benefits
- GLP-1 receptor agonist compound commonly researched in metabolic studies
- May support appetite regulation and satiety-related research models
- Frequently explored in weight management and glucose metabolism research contexts
- Pre-filled 6mg / 2ml pen format for precision, convenience, and ease of use
- Supports controlled and repeatable dosing in structured research applications
- Long-acting peptide profile suitable for extended research protocols
- Stable formulation designed for reliability, handling, and storage consistency
- Suitable for advanced laboratory and metabolic research workflows.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
